Combo Products Collaborative, Consultative Review Document Outlines SOPs
This article was originally published in The Gray Sheet
Executive Summary
FDA's interpretation of "primary mode of action," the principle underlying jurisdictional assignment of combination products, will be open for stakeholder comment during a second public meeting on the topic